Clinuvel Pharmaceuticals Ltd
CLVLF- Exchange
- OTC
- Industry
- American Depositary Receipts
- SEC CIK
- 0001290877
No open-market purchases or sales by Clinuvel Pharmaceuticals Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCUVL
Holders of 5% or more of CLVLF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Clinuvel Pharmaceuticals Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Clinuvel Pharmaceuticals Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Clinuvel Pharmaceuticals Ltd, newest first.
No Schedule 13D or 13G filings on Clinuvel Pharmaceuticals Ltd are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Clinuvel Pharmaceuticals Ltd shares.
No Form 144 notices for Clinuvel Pharmaceuticals Ltd are on file.